SCHEMBL162294

SCHEMBL162294

O=C(O)C1CNCCN1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL170308 1.00
SCHEMBL172309 1.00
Hydrochloric Acid SCHEMBL283015 0.98 CYP2D6 (0.41)
SCHEMBL28861034 0.98 CYP2D6 (0.41)
SCHEMBL28853863 0.98 CYP2D6 (0.41)
Hydrochloric Acid SCHEMBL191366 0.98 CYP2D6 (0.41)
Hydrochloric Acid SCHEMBL780213 0.98 CYP2D6 (0.41)
SCHEMBL4492257 0.98 CYP2D6 (0.41)
Hydrochloric Acid SCHEMBL28324857 0.98 CYP2D6 (0.41)
Hydrochloric Acid SCHEMBL26648780 0.98 CYP2D6 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3226 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4127157-B1 MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS ENCODIA INC (US) 2026-02-11 EP claimed
EP-4652183-A1 PEPTIDE-DRUG CONJUGATES FOR TARGETED THERAPY OF RENAL DISEASES Shanghai MicuRx Pharmaceutical Co., Ltd. (CN) 2025-11-26 EP claimed
US-20250230154-A1 COMPOUND HAVING SHP2 PROTEIN DEGRADING ACTIVITY, AND MEDICAL USES THEREOF UBIX THERAPEUTICS, INC. (KR) 2025-07-17 US claimed
CN-119752387-A Aldehyde-free polyurethane adhesive for high-conductivity leather products containing imidazole heterocycle ionic liquid and preparation method thereof 广东菲安妮皮具股份有限公司 2025-04-04 CN claimed
US-20250109171-A1 COMPOUNDS AND COMPOSITIONS FOR TARGETED THERAPY OF RENAL DISEASES Shanghai MICURX Pharmaceuticals Co., Ltd. (CN) 2025-04-03 US claimed
CN-119528936-A Ballon Sha Wei derivative and application thereof 深圳安泰维生物医药有限公司 2025-02-28 CN claimed
CN-119524634-A Method for preparing nanofiltration membrane based on molecular encapsulation nanocapsule self-catalyzed interfacial polymerization 蔚华膜科技(昆山)有限公司 2025-02-28 CN claimed
CN-119488818-A Preparation method of PPTA composite nanofiltration membrane with pore diameter optimized by utilizing hydrogel mosaic structure 上海工程技术大学 2025-02-21 CN claimed
CN-119330934-A Degradation agent of targeted Smurf1 protein, preparation method and application 中国人民解放军军事科学院军事医学研究院 2025-01-21 CN claimed
CN-119241539-A Pyrazolo piperidine (ketone) -containing derivative, and preparation method and application thereof 沈阳药科大学 2025-01-03 CN claimed
US-5886181-A ASYMMETRIC HYDROGENATION OF THE CORRESPONDING 1,4,5,6-TETRAHYDROPYRAZINES LONZA, LTD. (CH) 1999-03-23 US claimed
US-5856485-A RESOLUTION OF AN ENANTIOMORPH MIXTURE LONZA AG (CH) 1999-01-05 US claimed
EP-0695162-B1 DYES CONTAINING ISATIN FOR KERATIN-CONTAINING FIBRES HENKEL KGAA (DE) 1997-06-18 EP claimed
US-5616150-A HAIR DYES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1997-04-01 US claimed
EP-0756593-A1 PROCESS FOR PREPARING 2-PIPERAZINE CARBOXYLIC ACID DERIVATIVES LONZA AG (CH) 1997-02-05 EP claimed
EP-0691959-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1996-01-17 EP claimed
WO-1995029169-A2 PROCESS FOR PREPARING 2-PIPERAZINE CARBOXYLIC ACID DERIVATIVES LONZA AG (CH) 1995-11-02 WO claimed
WO-1994022834-A1 HETEROCYCLIC DERIVATIVES AS PLATELET AGGREGATION INHIBITORS ZENECA LIMITED (GB) 1994-10-13 WO claimed
EP-0159889-B1 4-SUBSTITUTED PIPERAZINE-2-CARBOXYLIC ACIDS PROCESS AND PHARMACEUTICAL COMPOSITIONS BTG INTERNATIONAL LIMITED (GB) 1992-09-30 EP claimed
EP-0159889-A2 4-Substituted piperazine-2-carboxylic acids process and pharmaceutical compositions BTG INTERNATIONAL LIMITED (GB) 1985-10-30 EP claimed